|18.54||-0.04 / -0.22%|
Data as of 3:59pm ET
|18.54||+0.0022 / +0.01%|
The 7 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 20.00, with a high estimate of 28.00 and a low estimate of 15.00. The median estimate represents a +7.87% increase from the last price of 18.54.
The current consensus among 9 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.